FOXO3 and urothelial carcinoma: Downregulation of FOXO3A expression promotes tumor occurrence, metastasis, and progression in breast cancer (13), gastric carcinoma (14), pancreatic ductal adenocarcinoma (15), cervical carcinoma (16), clear cell renal cell carcinoma (17), and urothelial carcinoma (18).